| STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer SP Totten, YK Im, E Cepeda Cañedo, O Najyb, A Nguyen, S Hébert, ... Nature Communications 12 (1), 3299, 2021 | 38 | 2021 |
| Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy? M Jangal, B Lebeau, M Witcher Expert opinion on therapeutic targets 23 (7), 565-578, 2019 | 31 | 2019 |
| POGZ promotes homology‐directed DNA repair in an HP1‐dependent manner J Heath, ES Cheyou, S Findlay, VM Luo, EP Carpio, J Lee, B Djerir, ... EMBO reports 23 (1), e51041, 2022 | 9 | 2022 |
| 3D chromatin remodeling potentiates transcriptional programs driving cell invasion B Lebeau, M Jangal, T Zhao, CK Wong, N Wong, EC Cañedo, S Hébert, ... Proceedings of the National Academy of Sciences 119 (36), e2203452119, 2022 | 6 | 2022 |
| Single base-pair resolution analysis of DNA binding motif with MoMotif reveals an oncogenic function of CTCF zinc-finger 1 mutation B Lebeau, K Zhao, M Jangal, T Zhao, M Guerra, CMT Greenwood, ... Nucleic Acids Research 50 (15), 8441-8458, 2022 | 4 | 2022 |
| MTOR modulation induces selective perturbations in histone methylation which influence the anti-proliferative effects of mTOR inhibitors HE Kim, B Lebeau, D Papadopoli, P Jovanovic, M Russo, D Avizonis, ... iScience, 2024 | | 2024 |
| Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth Y Zhang, K Chen, SC Tang, Y Cai, A Nambu, YX See, C Fu, A Raju, ... bioRxiv, 2023.08. 29.555291, 2023 | | 2023 |
| Studying the Oncogenic and Epigenetic Impact of CTCF Loss of Heterozygosity and Zinc-Finger 1 Mutation in Breast Cancer B Lebeau McGill University (Canada), 2022 | | 2022 |
| POGZ modulates the DNA damage response in a HP1-dependent manner J Heath, ES Cheyou, S Findlay, VM Luo, EP Carpio, J Lee, B Djerir, ... bioRxiv, 2021.06. 28.447216, 2021 | | 2021 |
